Beyond building better brains: Bridging the docosahexaenoic acid (DHA) gap of prematurity

Journal of Perinatology

Volumn 35, Issue 1, 2015, Pages 1-7

  Harris, W S ^a,b,c,d   Baack, M L ^a,e  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b OmegaQuant Analytics   (United States)

^c Health Diagnostics Laboratory Inc   (United States)

^d SANFORD RESEARCH   (United States)

^e Sanford Children's Health Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; UNSATURATED FATTY ACID;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ARTIFICIAL MILK; ATTENTION DISTURBANCE; BAYLEY SCALES OF INFANT DEVELOPMENT; BRAIN DEVELOPMENT; BREAST FEEDING; CHEMOPROPHYLAXIS; CLINICAL TRIAL (TOPIC); DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; ENTERIC FEEDING; ESSENTIAL FATTY ACID DEFICIENCY; FATTY ACID SYNTHESIS; HIGH RISK POPULATION; HUMAN; INFANT; INTELLIGENCE QUOTIENT; LEARNING DISORDER; LUNG DYSPLASIA; MEMORY CONSOLIDATION; MENTAL DEVELOPMENTAL INDEX; MORBIDITY; NECROTIZING ENTEROCOLITIS; NEUROPSYCHOLOGICAL TEST; NEWBORN MORTALITY; OUTCOME ASSESSMENT; POSTNATAL CARE; PREMATURITY; PSYCHOMOTOR DEVELOPMENTAL INDEX; RETROLENTAL FIBROPLASIA; VERY LOW BIRTH WEIGHT; BRAIN; DEFICIENCY; GROWTH, DEVELOPMENT AND AGING; INFANT, PREMATURE, DISEASES; METABOLISM; NERVOUS SYSTEM; NEWBORN; NUTRITIONAL REQUIREMENT; PHYSIOLOGY; VISION;

BRAIN; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS, UNSATURATED; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; NERVOUS SYSTEM; NUTRITIONAL REQUIREMENTS; VISION, OCULAR;

EID: 84920284729     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2014.195     Document Type: Article

References (58)

1. Agostoni C, Marangoni F, Stival G, Gatelli I, Pinto F, Rise P et al. Whole blood fatty acid composition differs in term versus mildly preterm infants: small versus matched appropriate for gestational age. Pediatr Res 2008; 64(3): 298-302.
2. Lapillonne A, Groh-Wargo S, Gonzalez CH, Uauy R. Lipid needs of preterm infants: updated recommendations. J Pediatr 2013; 162(3 Suppl): S37-S47.
3. Clandinin MT, Van Aerde JE, Merkel KL, Harris CL, Springer MA, Hansen JW et al. Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acid. J Pediatr 2005; 146(4): 461-468.
4. Henriksen C, Haugholt K, Lindgren M, Aurvag AK, Ronnestad A, Gronn M et al. Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid. Pediatrics 2008; 121(6): 1137-1145.
5. O'Connor DL, Hall R, Adamkin D, Auestad N, Castillo M, Connor WE et al. Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial. Pediatrics 2001; 108(2): 359-371.
6. Carlson SE, Werkman SH. A randomized trial of visual attention of preterm infants fed docosahexaenoic acid until two months. Lipids 1996; 31(1): 85-90.
7. Birch EE, Birch DG, Hoffman DR, Uauy R. Dietary essential fatty acid supply and visual acuity development. Invest Ophthalmol Vis Sci 1992; 33(11): 3242-3253.
8. Fewtrell MS, Abbott RA, Kennedy K, Singhal A, Morley R, Caine E et al. Randomized, double-blind trial of long-chain polyunsaturated fatty acid supplementation with fish oil and borage oil in preterm infants. J Pediatr 2004; 144(4): 471-479.
9. Isaacs EB, Ross S, Kennedy K, Weaver LT, Lucas A, Fewtrell MS. 10-year cognition in preterms after random assignment to fatty acid supplementation in infancy. Pediatrics 2011; 128(4): e890-e898.
10. Fang PC, Kuo HK, Huang CB, Ko TY, Chen CC, Chung MY. The effect of supplementation of docosahexaenoic acid and arachidonic acid on visual acuity and neurodevelopment in larger preterm infants. Chang Gung Med J 2005; 28(10): 708-715.
11. Makrides M, Gibson RA, McPhee AJ, Collins CT, Davis PG, Doyle LW et al. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial. JAMA 2009; 301(2): 175-182.
12. Smithers LG, Collins CT, Simmonds LA, Gibson RA, McPhee A, Makrides M. Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow-up study of a randomized controlled trial. Am J Clin Nutr 2010; 91(3): 628-634.
13. Westerberg AC, Schei R, Henriksen C, Smith L, Veierod MB, Drevon CA et al. Attention among very low birth weight infants following early supplementation with docosahexaenoic and arachidonic acid. Acta Paediatr 2011; 100(1): 47-52.
14. van Wezel-Meijler G, van der Knaap MS, Huisman J, Jonkman EJ, Valk J, Lafeber HN. Dietary supplementation of long-chain polyunsaturated fatty acids in preterm infants: effects on cerebral maturation. Acta Paediatr 2002; 91(9): 942-950.
15. Carlson SE, Werkman SH, Rhodes PG, Tolley EA. Visual-Acuity development in healthy preterm infants: effect of marine-oil supplementation. Am J Clin Nutr 1993; 58(1): 35-42.
16. Martin CR, Dasilva DA, Cluette-Brown JE, Dimonda C, Hamill A, Bhutta AQ et al. Decreased postnatal docosahexaenoic and arachidonic acid blood levels in premature infants are associated with neonatal morbidities. J Pediatr 2011; 159(5): 743-9 e1-2.
17. Tiesset H, Pierre M, Desseyn JL, Guery B, Beermann C, Galabert C et al. Dietary (n-3) polyunsaturated fatty acids affect the kinetics of pro- and antiinflammatory responses in mice with Pseudomonas aeruginosa lung infection. J Nutr 2009; 139 (1): 82-89.
18. Freedman SD, Weinstein D, Blanco PG, Martinez-Clark P, Urman S, Zaman M et al. Characterization of LPS-induced lung inflammation in cftr-/- mice and the effect of docosahexaenoic acid. J Appl Physiol 2002; 92(5): 2169-2176.
19. Joss-Moore LA, Wang Y, Baack ML, Yao J, Norris AW, Yu X et al. IUGR decreases PPARgamma and SETD8 Expression in neonatal rat lung and these effects are ameliorated by maternal DHA supplementation. Early Hum Dev 2010; 86(12): 785-791.
20. Rogers LK, Valentine CJ, Pennell M, Velten M, Britt RD, Dingess K et al. Maternal docosahexaenoic acid supplementation decreases lung inflammation in hyperoxia-exposed newborn mice. J Nutr 2011; 141(2): 214-222.
21. Rehan VK, Sakurai R, Corral J, Krebs M, Ibe B, Ihida-Stansbury K et al. Antenatally administered PPAR-gamma agonist rosiglitazone prevents hyperoxia-induced neonatal rat lung injury. Am J Physiol Lung Cell Mol Physiol 2010; 299(5): L672-L680.
22. Mayer K, Kiessling A, Ott J, Schaefer MB, Hecker M, Henneke I et al. Acute lung injury is reduced in fat-1 mice endogenously synthesizing n-3 fatty acids. Am J Respir Crit Care Med 2009; 179(6): 474-483.
23. Caplan MS, Russell T, Xiao Y, Amer M, Kaup S, Jilling T. Effect of polyunsaturated fatty acid (PUFA) supplementation on intestinal inflammation and necrotizing enterocolitis (NEC) in a neonatal rat model. Pediatr Res 2001; 49(5): 647-652.
24. Ohtsuka Y, Okada K, Yamakawa Y, Ikuse T, Baba Y, Inage E et al. omega-3 fatty acids attenuate mucosal inflammation in premature rat pups. J Pediatr Surg 2011; 46(3): 489-495.
25. Akisu M, Baka M, Coker I, Kultursay N, Huseyinov A. Effect of dietary n-3 fatty acids on hypoxia-induced necrotizing enterocolitis in young mice. n-3 fatty acids alter platelet-Activating factor and leukotriene B4 production in the intestine. Biol Neonate 1998; 74(1): 31-38.
26. Lu J, Jilling T, Li D, Caplan MS. Polyunsaturated fatty acid supplementation alters proinflammatory gene expression and reduces the incidence of necrotizing enterocolitis in a neonatal rat model. Pediatr Res 2007; 61(4): 427-432.
27. Carlson SE, Montalto MB, Ponder DL, Werkman SH, Korones SB. Lower incidence of necrotizing enterocolitis in infants fed a preterm formula with egg phospholipids. Pediatr Res 1998; 44(4): 491-498.
28. SanGiovanni JP, Chew EY. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res 2005; 24(1): 87-138.
29. Pawlik D, Lauterbach R, Turyk E. Fish-oil fat emulsion supplementation may reduce the risk of severe retinopathy in VLBW infants. Pediatrics 2011; 127(2): 223-228.
30. Connor KM, SanGiovanni JP, Lofqvist C, Aderman CM, Chen J, Higuchi A et al. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med 2007; 13(7): 868-873.
31. Heidary G, Vanderveen D, Smith LE. Retinopathy of prematurity: current concepts in molecular pathogenesis. Semin Ophthalmol 2009; 24(2): 77-81.
32. Matesanz N, Park G, McAllister H, Leahey W, Devine A, McVeigh GE et al. Docosahexaenoic acid improves the nitroso-redox balance and reduces VEGFmediated angiogenic signaling in microvascular endothelial cells. Invest Ophthalmol Vis Sci 2010; 51(12): 6815-6825.
33. Pawlik D, Lauterbach R, Walczak M, Hurkala J, Sherman MP. Fish-oil fat emulsion supplementation reduces the risk of retinopathy in very low birth weight infants: a prospective, randomized study. JPEN J Parenter Enteral Nutr 2013; 38(6): 711-716.
34. Beken S, Dilli D, Fettah ND, Kabatas EU, Zenciroglu A, Okumus N. The influence of fish-oil lipid emulsions on retinopathy of prematurity in very low birth weight infants: a randomized controlled trial. Early Hum Dev 2014; 90(1): 27-31.
35. Kuipers RS, Luxwolda MF, Offringa PJ, Boersma ER, Dijck-Brouwer DA, Muskiet FA. Fetal intrauterine whole body linoleic, arachidonic and docosahexaenoic acid contents and accretion rates. Prostaglandins Leukot Essent Fatty Acids 2012; 86(1-2): 13-20.
36. Brenna JT, Varamini B, Jensen RG, Diersen-Schade DA, Boettcher JA, Arterburn LM. Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide. Am J Clin Nutr 2007; 85(6): 1457-1464.
37. Lauritzen L, Jorgensen MH, Hansen HS, Michaelsen KF. Fluctuations in human milk long-chain PUFA levels in relation to dietary fish intake. Lipids 2002; 37(3): 237-244.
38. Berenhauser AC, Pinheiro do Prado AC, da Silva RC, Gioielli LA, Block JM. Fatty acid composition in preterm and term breast milk. Int J Food Sci Nutr 2012; 63(3): 318-325.
39. Berseth CL, Harris CL, Wampler JL, Hoffman DR, Diersen-Schade DA. Liquid human milk fortifier significantly improves docosahexaenoic and arachidonic acid status in preterm infants. Prostaglandins Leukot Essent Fatty Acids 2014; 91(3): 97-103.
40. Baack ML, Norris AW, Yao J, Colaizy T. Long-chain polyunsaturated fatty acid levels in US donor human milk: meeting the needs of premature infants?. J Perinatol 2012; 32(8): 598-603.
41. Wojcik KY, Rechtman DJ, Lee ML, Montoya A, Medo ET. Macronutrient analysis of a nationwide sample of donor breast milk. J Am Diet Assoc 2009; 109(1): 137-140.
42. Abranches AD, Soares FV, Junior SC, Moreira ME. Freezing and thawing effects on fat, protein, and lactose levels of human natural milk administered by gavage and continuous infusion. J Pediatr 2014; 90(4): 384-388.
43. Lucas A, Morley R, Cole TJ, Lister G, Leeson-Payne C. Breast milk and subsequent intelligence quotient in children born preterm. Lancet 1992; 339(8788): 261-264.
44. Drover JR, Hoffman DR, Castaneda YS, Morale SE, Garfield S, Wheaton DH et al. Cognitive function in 18-month-old term infants of the DIAMOND study: a randomized, controlled clinical trial with multiple dietary levels of docosahexaenoic acid. Early Hum Dev 2011; 87(3): 223-230.
45. Anderson P, Doyle LW. Neurobehavioral outcomes of school-Age children born extremely low birth weight or very preterm in the 1990s. JAMA 2003; 289(24): 3264-3272.
46. Colombo J, Carlson SE, Cheatham CL, Shaddy DJ, Kerling EH, Thodosoff JM et al. Long-Term effects of LCPUFA supplementation on childhood cognitive outcomes. Am J Clin Nutr 2013; 98(2): 403-412.
47. Qawasmi A, Landeros-Weisenberger A, Leckman JF, Bloch MH. Meta-Analysis of long-chain polyunsaturated fatty acid supplementation of formula and infant cognition. Pediatrics 2012; 129(6): 1141-1149.
48. Tanaka K, Kon N, Ohkawa N, Yoshikawa N, Shimizu T. Does breastfeeding in the neonatal period influence the cognitive function of very-low-birth-weight infants at 5 years of age?. Brain Dev 2009; 31(4): 288-293.
49. Koren N, Simsa-Maziel S, Shahar R, Schwartz B, Monsonego-Ornan E. Exposure to omega-3 fatty acids at early age accelerate bone growth and improve bone quality. J Nutr Biochem 2014; 25(6): 623-633.
50. Manley BJ, Makrides M, Collins CT, McPhee AJ, Gibson RA, Ryan P et al. High-dose docosahexaenoic acid supplementation of preterm infants: respiratory and allergy outcomes. Pediatrics 2011; 128(1): e71-e77.
51. Koletzko B, Lien E, Agostoni C, Bohles H, Campoy C, Cetin I et al. The roles of longchain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med 2008; 36(1): 5-14.
52. Bowen RA, Wierzbicki AA, Clandinin MT. Does increasing dietary linolenic acid content increase the docosahexaenoic acid content of phospholipids in neuronal cells of neonatal rats?. Pediatr Res 1999; 45(6): 815-819.
53. Al-Tamer YY, Mahmood AA. The influence of Iraqi mothers' socioeconomic status on their milk-lipid content. Eur J Clin Nutr 2006; 60(12): 1400-1405.
54. Dunstan JA, Mitoulas LR, Dixon G, Doherty DA, Hartmann PE, Simmer K et al. The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatr Res 2007; 62(6): 689-694.
55. Weiss GA, Troxler H, Klinke G, Rogler D, Braegger C, Hersberger M. High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation. Lipids Health Dis 2013; 12: 89.
56. Chappell JE, Clandinin MT, McVey MA, Chance GW. Free fatty acid content of human milk: physiologic significance and artifactual determinants. Lipids 1985; 20 (4): 216-221.
57. Yee JK, Mao CS, Ross MG, Lee WN, Desai M, Toda A et al. High oleic/stearic fattyacid desaturation index in cord plasma from infants of mothers with gestational diabetes. J Perinatol 2014; 34(5): 357-363.
58. Thomas BA, Ghebremeskel K, Lowy C, Offley-Shore B, Crawford MA. Plasma fatty acids of neonates born to mothers with and without gestational diabetes. Prostaglandins Leukot Essent Fatty Acids 2005; 72(5): 335-341.